Preclinical Development - Biomolecular - ADME

(M1130-02-07) Comparative In Vivo Stability of Tumor Targeting Antibodies Labeled Using Three Distinct Radioiodination Methods

(T1130-02-08) In Vitro Lymphatic Absorption Screening with Primary Human Small Intestinal Cells

(M1130-02-08) Sex Hormone-Dependent Regulation of MCT1 on the Blood Brain Barrier

(T1130-02-10) Positively Charged Surface in LIGHT Trimers Fused with Fc, a Ligand for Lymphotoxin-b Receptor (LTbR) and HVEM, Caused a Non-specific Interaction with Cells Leading to Fast Systemic Clearance in Mice

(T1330-02-08) Pharmacokinetics of Speciofoline, a Minor Kratom Alkaloid in Sprague-Dawley Rats

(M1330-02-11) Artificial Extracellular Matrices as Tools for In Vivo Injectable Formulation Analysis

(M1330-02-12) PET/CT Imaging of Bleomycin-Induced Murine Pulmonary Fibrosis Using a Radiolabeled PEGylated Functional Upstream Domain Peptide

(T1430-02-08) Spectinamide 1599 Exposure in Lung, ELF and Plasma after Passive Inhalation in Mice

(M0930-02-07) Using the In Vitro Dissolution Absorption System (IDAS) to Evaluate the Effects of Excipients on the Permeation of Putative Biopharmaceutics Classification System Class III Drugs

(W1230-02-08) In Vitro Comparative Dissolution and Permeation Testing Using the In Vitro Dissolution Absorption System (IDAS) for Expanding Biowaivers to Non Q1/Q2 BCS Class III Products